In conclusion, L1, differentially expressed in retinoblastoma cells and tumors, increases proliferation and chemoresistance of retinoblastoma through the modulation of intracellular signaling cascades, PI3K/Akt and MAPK pathways. This evidence concerns the gene AKT1 and retinoblastoma.